Selank is not a classic nootropic. It is a dedicated cognitive homeostasis modulator—a heptapeptide analog of Tuftsin (Thr-Lys-Pro-Arg-Pro-Gly-Pro) that re-balances GABA, serotonin, and BDNF without receptor binding and without dependency loop. Russian research heritage, anxiolysis without sedation.
The biochemical premise—a heptapeptide modulator without addiction circuit
In the peptide research field, anxiolytic research models are typically dominated by GABA-A receptor agonists (benzodiazepine analogs)—and these carry one inevitable burden: receptor downregulation, tachyphylaxis, and withdrawal circuits.
Selank breaks that paradigm. Instead of directly binding to GABA-A, it modulates GABAergic tone indirectly via enkephalin system stabilization and serotonin transporter regulation. The result in in-vitro and pre-clinical models: measurable anxiolysis without sedation, without amnestic side effects, and without withdrawal phenomena up to chronic exposure.
Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro, MW: 751.88 g/mol) is a synthetic heptapeptide derived from the immune cell fragment Tuftsin (Thr-Lys-Pro-Arg), extended with a Pro-Gly-Pro tail for enzymatic stability and blood-brain barrier penetration.
"Benzodiazepines silence the brain. Selank teaches the brain to balance itself."
In that respect, Selank is fundamentally different from classical "anxiolytic research compounds"—it does not function as a sedative, not as a GABA-A agonist, and not as a monoamine reuptake inhibitor. It operates upstream at the level of neuropeptide balance and BDNF expression—a more fundamental homeostasis position in the central nervous system.
What does Selank do razor-sharp differently?
Selank (TKPRPGP-Cu²⁺-free, MW: 751.88 g/mol) operates on multiple layers simultaneously:
- GABAergic tone modulation without receptor binding → indirect balance effect via enkephalin stabilization
- Serotonin transporter (SERT) downregulation → measurable elevation of extracellular 5-HT in raphe nuclei models
- BDNF upregulation in hippocampus → support of neuroplasticity and memory consolidation
- Enkephalin-degrading enzyme inhibition → endogenous opioid tone stabilization without exogenous opioid binding
- Dopamine D2-receptor sensitivity modulation → balance between motivation and stress response
- Anti-inflammatory response in microglia (reduced IL-6, TNF-α in chronic stress models)
- No tachyphylaxis in chronic exposure—unique for anxiolytic research compounds
Selank vs Semax—Side-by-Side
| Property | Selank (Cognitive Homeostasis) | Semax (Cognitive Acceleration) |
|---|---|---|
| Sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro | Met-Glu-His-Phe-Pro-Gly-Pro |
| Origin fragment | Tuftsin (immunopeptide) | ACTH 4-7 (hormone fragment) |
| Molecular mass | 751.88 g/mol | 813.94 g/mol |
| Primary research domain | Anxiolysis · mood balance · GABA/serotonin | Cognition · BDNF · neuroprotection |
| GABAergic modulation | Strong (indirect, via enkephalin) | Limited |
| Serotonin system | SERT downregulation · 5-HT elevation | Minimal |
| BDNF upregulation in hippocampus | Strong | Very strong |
| Dopamine modulation | D2-sensitivity balance | D2/D3 acute activation |
| Cognitive focus response | Moderate (calm-clear profile) | Strong · acute attention boost |
| Anxiolysis without sedation | Yes (signature effect) | Not primary |
| Withdrawal/tachyphylaxis | None in chronic models | None |
| HPLC-purity Primal lot | ≥99% | ≥99% |
| Reconstitution | Bacteriostatic water · −20 °C | Bacteriostatic water · −20 °C |
| Optimal research role | Mood balance research · anti-stress | Cognitive performance research |
The biochemical conclusion: Semax is the acute cognitive accelerator—it rapidly elevates attention, BDNF, and dopamine. Selank is the homeostatic re-balancer—it returns GABAergic tone, serotonin, and neuropeptide balance to a calm-clear equilibrium. Both are complementary, not substitutes. In comparative in-vitro models, Selank+Semax is often positioned as a "calm focus" research protocol.
The Molecular Mechanics
At the level of central nervous system cultures and in-vivo behavioral models, the following effects of Selank are documented:
- GABAergic tone elevated without GABA-A receptor binding—indirect via enkephalin system modulation
- Enkephalin-degrading peptidase inhibition → extended endogenous Met-enkephalin half-life
- Anxiolytic response in elevated-plus-maze models without motor ataxia or sedation
- No amnestic side effects in memory-test models (versus benzodiazepine control)
- No receptor downregulation in chronic exposure in chronic in-vitro models
- Synergistic effect with SSRI research models in animal studies (additive response without serotonin syndrome markers)
For research into mood regulation and monoamine balance, Selank delivers a unique profile:
- SERT (serotonin transporter) expression modulated → measurable elevation of extracellular 5-HT in raphe nuclei
- 5-HT1A receptor sensitivity elevated in hippocampal cultures
- Dopamine D2-receptor balance restored in chronic stress models
- Norepinephrine homeostasis supported without acute sympathetic activation
- HPA-axis modulation → reduced cortisol response in chronic stress models
- Anti-anhedonia response in sucrose-preference test models
The most unique Selank property is measurable cognitive clarity without the acute "push" of classic nootropics:
- BDNF upregulation in hippocampus → support of neuroplasticity and memory consolidation
- NGF (Nerve Growth Factor) elevated in animal models—synaptic density reinforced
- Microglia activation dampened → reduced IL-6, TNF-α in chronic neuroinflammation cultures
- Improved attention without hyperactivity in attention-task models
- No tachyphylaxis in chronic in-vitro models chronic exposure—unique for anxiolytic peptide research
- Cognitive clarity maintained without sedation or "brain fog" markers
The Primal Peptides standard
Every batch is independently validated. The Certificate of Analysis (COA) is the binding source of truth for each lot—publicly available, batch-specific, and generated by an independent third-party laboratory prior to shipment. We publish no claims not supported per lot by the COA.
- 01RP-HPLC with UV detection → purity ≥ 98–99%
- 02Mass spectrometry → molecular mass confirmation
- 03Janoshik 3rd-party verification → public COA per lot
Our validation architecture is deliberately minimalist and strict: three reproducible assays, one independent verification, one public certificate. For the complete analytical dossier of your specific batch, consult the COA with your shipment or via our public verification page.
Selank modulates the central nervous system on multiple levels simultaneously (GABAergic, serotonergic, dopaminergic, BDNF). Research protocols must strictly control monoamine baselines, cortisol rhythms, and potential co-administration with other CNS-active research compounds (SSRIs, MAO inhibitors) in animal models.
Legal disclaimer: Selank is intended exclusively for IN-VITRO RESEARCH. Not for human use. Not for consumption. Not for nasal or oral application.
Conclusion—The architect of neurological balance
Selank is not another nootropic. It is a dedicated cognitive homeostasis modulator that re-balances GABA, serotonin, dopamine, and BDNF via neuropeptide stabilization—without receptor binding, without sedation, without withdrawal. For researchers who wish to study anxiolytic mechanisms, mood balance, and neuropeptide homeostasis in a molecularly targeted manner, Selank is the missing heptapeptide instrument.
Balance over silence. Clarity over sedation. Homeostasis over hyperactivity.
Selank
Vertailustandardi suoraan Primal Peptides EU -laboratoriosta – tyhjiöpakattu, anonymisoitu ja huomaamattomasti lähetetty EU:n sisällä. Tiukat –20 °C säilytysprotokollat ennen lähetystä takaavat eräeheyden.
VAIN IN-VITRO-TUTKIMUSKÄYTTÖÖN · EI IHMISKÄYTTÖÖN · GMP-VAATIMUSTEN MUKAINEN SYNTEESI